Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,612,277 papers from all fields of science
Search
Sign In
Create Free Account
Oncolytic Virotherapy
Known as:
Virotherapy, Oncolytic
, Virotherapies, Oncolytic
, Oncolytic Virotherapies
Expand
Treatment using an oncolytic virus (a virus that infects and breaks down cancer cells but not normal cells). Oncolytic virus therapy may make it…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Biological Response Modifier Therapy
Oncolytic Viruses
nursing therapy
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
S. Patil
,
I. Gentschev
,
+6 authors
A. Szalay
PLoS ONE
2012
Corpus ID: 14045401
Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for cancer therapy. We have previously…
Expand
Review
2010
Review
2010
The evolving role of dendritic cells in cancer therapy
E. Ilett
,
Rjd Prestwich
,
A. Melcher
Expert Opinion on Biological Therapy
2010
Corpus ID: 27977954
Importance of the field: Dendritic cells (DC) are a clear choice for use in cancer immunotherapy, and much research has focused…
Expand
Review
2009
Review
2009
Review article: investigational agents for chronic hepatitis C
A. Thompson
,
J. Mchutchison
Alimentary Pharmacology and Therapeutics
2009
Corpus ID: 22134828
Background The need for effective treatment for chronic hepatitis C infection has driven the development of novel antiviral…
Expand
Highly Cited
2008
Highly Cited
2008
Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.
Shu-Fu Lin
,
D. Price
,
+9 authors
R. Wong
Journal of Clinical Endocrinology and Metabolism
2008
Corpus ID: 26103492
CONTEXT Anaplastic thyroid carcinoma (ATC) is a fatal disease with a median survival of only 6 months. Novel therapies are needed…
Expand
Review
2005
Review
2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
S. Thorne
,
T. Hermiston
,
D. Kirn
Seminars in Oncology
2005
Corpus ID: 25428915
The application of replicating viruses for the treatment of cancers represents a novel therapy that is distinct from traditional…
Expand
Highly Cited
2003
Highly Cited
2003
Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons.
J. Jebbink
,
X. Bai
,
B. Rogers
,
D. Dawson
,
R. Scheuermann
,
R. Domiati-Saad
Journal of Molecular Diagnostics
2003
Corpus ID: 35870022
Review
2002
Review
2002
Virotherapy clinical trials for regional disease: In situ immune modulation using recombinant poxvirus vectors
M. Mastrangelo
,
E. Lattime
Cancer Gene Therapy
2002
Corpus ID: 25791502
The ability of viruses to readily infect tumor cells both in vitro and in vivo has resulted in their study as antitumor agents…
Expand
2002
2002
Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences.
N. Gilbert
,
S. Corden
,
S. Ijaz
,
P. Grant
,
R. Tedder
,
E. Boxall
Journal of Virological Methods
2002
Corpus ID: 24018191
Review
2001
Review
2001
Cancer gene therapy by adenovirus-mediated gene transfer.
Q. Wu
,
T. Moyana
,
J. Xiang
Current Gene Therapy
2001
Corpus ID: 28713782
Cancer arises as a direct result of genetic mutations. It therefore stands to reason that cancer should be well suited for the…
Expand
1995
1995
Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation.
S. Singhal
,
J. Mehta
,
+5 authors
B. Jameson
Bone Marrow Transplantation
1995
Corpus ID: 23387774
Cytomegaloviraemia diagnosed by early antigen detection or conventional viral culture from blood occurred 7-71 days (median 41…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE